| Industry: Pharmaceuticals |
|
| 1 |
Johnson & Johnson |
36 |
53,324 |
6 |
11,053 |
6 |
| 2 |
Pfizer |
39 |
52,415 |
2 |
19,337 |
139 |
| 3 |
Merck |
99 |
22,636 |
3 |
4,434 |
-4 |
| 4 |
Abbott Laboratories |
102 |
22,476 |
1 |
1,717 |
-49 |
| 5 |
Wyeth |
113 |
20,351 |
9 |
4,197 |
15 |
| 6 |
Bristol-Myers Squibb |
129 |
17,914 |
-11 |
1,585 |
-47 |
| 7 |
Eli Lilly |
149 |
15,691 |
7 |
2,663 |
35 |
| 8 |
Amgen |
171 |
14,268 |
15 |
2,950 |
-20 |
| 9 |
Schering-Plough |
242 |
10,594 |
11 |
1,143 |
325 |
| 10 |
Genzyme |
620 |
3,187 |
17 |
-17 |
-104 |
| 11 |
Allergan |
644 |
3,063 |
32 |
-127 |
-132 |
| 12 |
Gilead Sciences |
649 |
3,026 |
49 |
-1,190 |
-246 |
| 13 |
Forest Laboratories |
655 |
2,962 |
-6 |
709 |
-16 |
| 14 |
Hospira |
697 |
2,689 |
2 |
238 |
1 |
| 15 |
Biogen Idec |
698 |
2,683 |
11 |
218 |
35 |
| 16 |
King Pharmaceuticals |
862 |
1,989 |
12 |
289 |
145 |
| 17 |
Watson Pharmaceuticals |
865 |
1,979 |
20 |
-445 |
-422 |
| 18 |
NBTY |
893 |
1,880 |
8 |
112 |
43 |
| 19 |
Cephalon |
930 |
1,764 |
46 |
145 |
N.A. |
From the April 30th, 2007 issue
|
| Most profitable companies |
| Fortune 500 methodology |
| Included in the survey are U.S. incorporated companies filing financial statements with a government agency. This includes private companies... (more)
|
|
